Cargando…
Developing Biomimetic Hydrogels of the Arterial Wall as a Prothrombotic Substrate for In Vitro Human Thrombosis Models
Current in vitro thrombosis models utilise simplistic 2D surfaces coated with purified components of the subendothelial matrix. The lack of a realistic humanised model has led to greater study of thrombus formation in in vivo tests in animals. Here we aimed to develop 3D hydrogel-based replicas of t...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10298383/ https://www.ncbi.nlm.nih.gov/pubmed/37367147 http://dx.doi.org/10.3390/gels9060477 |
_version_ | 1785064101762826240 |
---|---|
author | Ranjbar, Jacob Njoroge, Wanjiku Gibbins, Jonathan M. Roach, Paul Yang, Ying Harper, Alan G. S. |
author_facet | Ranjbar, Jacob Njoroge, Wanjiku Gibbins, Jonathan M. Roach, Paul Yang, Ying Harper, Alan G. S. |
author_sort | Ranjbar, Jacob |
collection | PubMed |
description | Current in vitro thrombosis models utilise simplistic 2D surfaces coated with purified components of the subendothelial matrix. The lack of a realistic humanised model has led to greater study of thrombus formation in in vivo tests in animals. Here we aimed to develop 3D hydrogel-based replicas of the medial and adventitial layers of the human artery to produce a surface that can optimally support thrombus formation under physiological flow conditions. These tissue-engineered medial- (TEML) and adventitial-layer (TEAL) hydrogels were developed by culturing human coronary artery smooth muscle cells and human aortic adventitial fibroblasts within collagen hydrogels, both individually and in co-culture. Platelet aggregation upon these hydrogels was studied using a custom-made parallel flow chamber. When cultured in the presence of ascorbic acid, the medial-layer hydrogels were able to produce sufficient neo-collagen to support effective platelet aggregation under arterial flow conditions. Both TEML and TEAL hydrogels possessed measurable tissue factor activity and could trigger coagulation of platelet-poor plasma in a factor VII-dependent manner. Biomimetic hydrogel replicas of the subendothelial layers of the human artery are effective substrates for a humanised in vitro thrombosis model that could reduce animal experimentation by replacing current in vivo models. |
format | Online Article Text |
id | pubmed-10298383 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-102983832023-06-28 Developing Biomimetic Hydrogels of the Arterial Wall as a Prothrombotic Substrate for In Vitro Human Thrombosis Models Ranjbar, Jacob Njoroge, Wanjiku Gibbins, Jonathan M. Roach, Paul Yang, Ying Harper, Alan G. S. Gels Article Current in vitro thrombosis models utilise simplistic 2D surfaces coated with purified components of the subendothelial matrix. The lack of a realistic humanised model has led to greater study of thrombus formation in in vivo tests in animals. Here we aimed to develop 3D hydrogel-based replicas of the medial and adventitial layers of the human artery to produce a surface that can optimally support thrombus formation under physiological flow conditions. These tissue-engineered medial- (TEML) and adventitial-layer (TEAL) hydrogels were developed by culturing human coronary artery smooth muscle cells and human aortic adventitial fibroblasts within collagen hydrogels, both individually and in co-culture. Platelet aggregation upon these hydrogels was studied using a custom-made parallel flow chamber. When cultured in the presence of ascorbic acid, the medial-layer hydrogels were able to produce sufficient neo-collagen to support effective platelet aggregation under arterial flow conditions. Both TEML and TEAL hydrogels possessed measurable tissue factor activity and could trigger coagulation of platelet-poor plasma in a factor VII-dependent manner. Biomimetic hydrogel replicas of the subendothelial layers of the human artery are effective substrates for a humanised in vitro thrombosis model that could reduce animal experimentation by replacing current in vivo models. MDPI 2023-06-10 /pmc/articles/PMC10298383/ /pubmed/37367147 http://dx.doi.org/10.3390/gels9060477 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Ranjbar, Jacob Njoroge, Wanjiku Gibbins, Jonathan M. Roach, Paul Yang, Ying Harper, Alan G. S. Developing Biomimetic Hydrogels of the Arterial Wall as a Prothrombotic Substrate for In Vitro Human Thrombosis Models |
title | Developing Biomimetic Hydrogels of the Arterial Wall as a Prothrombotic Substrate for In Vitro Human Thrombosis Models |
title_full | Developing Biomimetic Hydrogels of the Arterial Wall as a Prothrombotic Substrate for In Vitro Human Thrombosis Models |
title_fullStr | Developing Biomimetic Hydrogels of the Arterial Wall as a Prothrombotic Substrate for In Vitro Human Thrombosis Models |
title_full_unstemmed | Developing Biomimetic Hydrogels of the Arterial Wall as a Prothrombotic Substrate for In Vitro Human Thrombosis Models |
title_short | Developing Biomimetic Hydrogels of the Arterial Wall as a Prothrombotic Substrate for In Vitro Human Thrombosis Models |
title_sort | developing biomimetic hydrogels of the arterial wall as a prothrombotic substrate for in vitro human thrombosis models |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10298383/ https://www.ncbi.nlm.nih.gov/pubmed/37367147 http://dx.doi.org/10.3390/gels9060477 |
work_keys_str_mv | AT ranjbarjacob developingbiomimetichydrogelsofthearterialwallasaprothromboticsubstrateforinvitrohumanthrombosismodels AT njorogewanjiku developingbiomimetichydrogelsofthearterialwallasaprothromboticsubstrateforinvitrohumanthrombosismodels AT gibbinsjonathanm developingbiomimetichydrogelsofthearterialwallasaprothromboticsubstrateforinvitrohumanthrombosismodels AT roachpaul developingbiomimetichydrogelsofthearterialwallasaprothromboticsubstrateforinvitrohumanthrombosismodels AT yangying developingbiomimetichydrogelsofthearterialwallasaprothromboticsubstrateforinvitrohumanthrombosismodels AT harperalangs developingbiomimetichydrogelsofthearterialwallasaprothromboticsubstrateforinvitrohumanthrombosismodels |